BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:38 PM
 | 
Jun 25, 2009
 |  BC Extra  |  Clinical News

Insmed falls on iPlex data

Insmed Inc. (NASDAQ:INSM) fell $1.25 (54%) to $1.08 on Thursday after data from a Phase II trial to treat myotonic muscular dystrophy (MMD) showed that iPlex produced no significant improvements in functional measures of endurance as measured by the...

Read the full 181 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >